Patients with advanced soft tissue sarcoma could now benefit from PharmaMar’s new drug trabectedin, after the NICE granted its approval. …
NICE is moving to update its clinical guidance on the management of chronic heart failure in adults. Draft recommendations are …
Few NHS trusts are following NICE’s 2006 guidelines on dementia, according central government auditor the National Audit Office. A NAO …
NICE has published a commissioning guide to help primary and secondary care teams recognise, treat and manage adult schizophrenia. The …

Includes online petition against NICE decision, Shire brings ADHD to Twitter, ViiV joins Twitter, Doctors.net.uk launches iPhone app and Diabetes …
NICE has rejected Sanofi-Aventis’ new anti-blood clot treatment Multaq (dronedarone) for use on the NHS because of its cost. According …

Andrew Dillon, chief executive of the National Institute for Health and Clinical Excellence (NICE), has been knighted in the 2010 …

Roche will have to present a stronger case for arthritis drug RoActemra in order to gain approval, according to NICE. …
A government programme offering workplace support for people with mental health issues has been launched.The idea is to allow sufferers …

Last week it was the ABPI that joined Twitter this week it’s UK cost effectiveness watchdog
The UK government is seeking industry input on its proposed pilot scheme to improve patient access to innovative drugs …
NICE has approved Janssen-Cilag’s Stelara as a treatment option for adults with moderate to severe plaque psoriasis.Part of the process …
The UK pharma industry has urged caution over data collected on the use of NICE-approved drugs on the NHS that …
NICE has recommended Lilly and Daiichi’s Efient for use on the NHS, giving the blood-thinner drug a boost in its …
Three treatments for advanced kidney cancer have been rejected by NICE, sparking criticism from pharma companies and patient groups.The drugs …